Early Versus Delayed Laparoscopic Cholecystectomy for Acute Cholecystitis

NCT ID: NCT07101315

Last Updated: 2025-08-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

81 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-01-01

Study Completion Date

2023-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to learn if performing gallbladder surgery early is as safe and effective as delaying it for people with acute cholecystitis (a sudden gallbladder infection). The main questions it aims to answer are:

* Do participants who have early surgery have a similar rate of complications compared to those who have delayed surgery?
* How does the timing of surgery affect the length of the hospital stay?

Researchers will compare two groups:

1. An early surgery group
2. A delayed surgery group

Participants in the early surgery group had their gallbladder removed within 72 hours of when their symptoms started. Participants in the delayed surgery group were first treated with medications and had their surgery 6-8 weeks later.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Cholecystitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Early Laparoscopic Cholecystectomy (ELC)

Participants underwent laparoscopic cholecystectomy within 72 hours of symptom onset during the index hospital admission.

Group Type EXPERIMENTAL

Laparoscopic Cholecystectomy

Intervention Type PROCEDURE

Standard four-port laparoscopic cholecystectomy was performed by a specialist or resident surgeon.

Delayed Laparoscopic Cholecystectomy (DLC)

Participants received initial non-operative management with antibiotics and analgesics, followed by elective laparoscopic cholecystectomy 6-8 weeks later.

Group Type ACTIVE_COMPARATOR

Laparoscopic Cholecystectomy

Intervention Type PROCEDURE

Standard four-port laparoscopic cholecystectomy was performed by a specialist or resident surgeon.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Laparoscopic Cholecystectomy

Standard four-port laparoscopic cholecystectomy was performed by a specialist or resident surgeon.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Yemeni nationals aged 18-70 years
* A clinical diagnosis of acute cholecystitis confirmed by clinical presentation, laboratory findings, and imaging studies
* Symptom duration of less than 72 hours at presentation
* Fitness for general anesthesia (American Society of Anesthesiologists \[ASA\] physical status classification I-III)
* Provision of written informed consent

Exclusion Criteria

* Evidence of choledocholithiasis or acute cholangitis
* Severe comorbidities precluding surgery (ASA class IV-V)
* Coagulopathy (INR \>1.5 or platelet count \<100,000/μL)
* Pregnancy
* Previous major upper abdominal surgery
* Patient refusal to participate
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Al-Thawra Modern General Hospital

OTHER

Sponsor Role collaborator

Al-Kuwait University Hospital

UNKNOWN

Sponsor Role collaborator

Sana'a University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Haitham Mohammed Jowah

Lecturer

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mohammed A Issa, Professor

Role: PRINCIPAL_INVESTIGATOR

Sana'a University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Al-Kuwait University Hospital

Sanaa, , Yemen

Site Status

Al-Thawra Modern General Hospital

Sanaa, , Yemen

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Yemen

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SanaaU-Chole-001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Cholecystectomy During Weekends
NCT06559449 COMPLETED